IRIS
LIVE

Serial Number

97855498

Owner

Iris Medicine, Inc.

Attorney

Syed Abedi

First Use Date

Aug 9, 2023

Filing Date

Mar 24, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IRIS Trademark

Serial Number: 97855498 • Registration: 7726808

IRIS is a trademark filed by Iris Medicine, Inc. on March 24, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Iris Medicine, Inc. (6 trademarks)

2630 Bancroft Way
Berkeley, CA 94704

Entity Type: 03

Trademark Details

Filing Date

March 24, 2023

Registration Date

March 18, 2025

First Use Anywhere

August 9, 2023

First Use in Commerce

August 9, 2023

Published for Opposition

January 28, 2025

Goods & Services

Pharmaceutical preparations for the treatment of genetic diseases, namely, neurological diseases; pharmaceutical preparations, namely, RNA therapeutics for use in the treatment of genetic diseases, namely, neurological diseases

Clinical preparations in the nature of RNA and genetic material, namely, plasmids, DNA, and chemically-modified RNA encoding RNA for use in the manufacture of medical preparations for treatment of genetic diseases

Development of pharmaceutical preparations and medicines for genetic diseases, namely, neurological diseases; testing, inspection, research, and development of pharmaceutical preparations for genetic diseases, namely, neurological diseases; none of the foregoing research services directed to providing a database comprising patient records to others in the fields of eyecare or ophthalmology

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2025 NONP
EXPARTE APPEAL TERMINATED
Oct 25, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 25, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 29, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 29, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Jul 29, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 29, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jul 29, 2024 EXAF
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jul 12, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 12, 2024 PARI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 23, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 23, 2024 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 29, 2024 GNFN
FINAL REFUSAL E-MAILED
Jan 29, 2024 GNFR
FINAL REFUSAL WRITTEN
Jan 29, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 22, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 3, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 3, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 3, 2023 CNRT
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sep 29, 2023 AAUA
USE AMENDMENT ACCEPTED
Sep 28, 2023 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Sep 23, 2023 AUPC
USE AMENDMENT FILED
Sep 23, 2023 IUAF
TEAS AMENDMENT OF USE RECEIVED
Sep 22, 2023 EAAU
ASSIGNED TO EXAMINER
Sep 14, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 18, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2023 NWOS
NEW APPLICATION ENTERED
Mar 28, 2023 NWAP